Florida Court Nixes $7 Million Acne Drug Award
A three-judge panel has reversed a $7 million judgment against the maker of the acne drug Accutane.
The 1st District Court of Appeal panel ruled in favor of Hoffman-La Roche Inc. and against a Pensacola man who had most of his colon removed due to Crohn’s disease linked to Accutane.
The unanimous opinion said the patient, Adam Mason, failed to prove an allegedly deficient warning label was the proximate cause of his ailment.
Mason had argued warning that Accutane was “temporally associated” with inflammatory bowel disease was too weak.
But his dermatologist testified he would have prescribed the drug even if the warning had been stronger.
Copyright 2024 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Popular Today
- Growing Progressive Set to Hire 10,000 for Claims, IT, Other Roles
- Work Safety Group Releases List of ‘Dirty Dozen’ Employers
- 4,800 Claims Handled by Unlicensed Adjusters in Florida After Irma, Lawsuit Says
- Insurers Get Green Light to Pay Less Than Billed Charges in Florida PIP Cases
Popular This Month
- Poll: Consumers OK with AI in P/C Insurance, but Not So Much for Claims and Underwriting
- CoreLogic Report Probes Evolving Severe Convective Storm Risk Landscape
- Millions of Recalled Hyundai and Kia Vehicles, With Dangerous Defect, Remain on Road
- California Chiropractor Sentenced to 54 Years for $150M Workers’ Comp Scheme